DUBLIN--(BUSINESS WIRE)--The "Europe Implantable Cardiac Monitors Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The Europe Implantable Cardiac Monitors Market is expected to witness market growth of 7.3% CAGR during the forecast period (2017-2023).
Presently, growing cases of cardiovascular diseases, remote monitoring systems and increasing use of implantable cardiac monitors to monitor epilepsy disorder accelerating the market growth. Furthermore, technological advancements in cardiac monitor devices such as miniaturization and easier implant procedures is further supporting the market growth.
Based on indication, the market report segments the market into Cardiac Arrhythmias, Atrial Fibrillation, and Epilepsy & Unexplained Falls. The end user segment covers Hospitals, Cardiac Center & Clinics, and Ambulatory Surgical Centers (ASCs). Based on countries, the Implantable Cardiac Monitors market segments the market into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Key Topics Covered
1. Market Scope & Methodology
2. Market Overview
3. Europe Implantable Cardiac Monitors Market
4. Europe Implantable Cardiac Monitors Market by End-user
5. Europe Implantable Cardiac Monitors Market by Country
6. Company Profiles
- Abiomed, Inc.
- Abbott Laboratories
- Boston Scientific Corporation
- Reliant Heart, Inc.
- Astellas Pharma inc.
- Thoratec Corporation St. (Jude Medical, LLC)
- Agilent Technologies, Inc.
- Berlin Heart GmbH
- Schiller AG
- Jarvik Heart, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/rk7r9c/implantable?w=4